Washington Dc, DCNCT03633955Now EnrollingIRB Ready

Acute Lymphocytic Leukemia Clinical Trial in Washington Dc, DC

Access cutting-edge acute lymphocytic leukemia treatment through this phase 1 clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.

Sponsored by University of Oklahoma

Quick Self-Assessment

See if you qualify for this Washington Dc location

Preparing your pre-screening questions…

Expert Care in Washington Dc

Access acute lymphocytic leukemia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related acute lymphocytic leukemia treatment provided free

Apply for This Washington Dc Location

Check if you qualify for this acute lymphocytic leukemia clinical trial in Washington Dc, DC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Washington Dc

    Convenient for DC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Washington Dc site if eligible
  4. 4Begin participation

About This Acute Lymphocytic Leukemia Study in Washington Dc

This is a prospective pilot study, the primary aim of which is to determine whether the presence of 18F FLT imaging signal uptake abnormalities correlate with clinically validated evidence of hematopoietic malignant disease (e.g. MRD, molecular, flow or histology) after immunotherapy and other treatments.

Sponsor: University of Oklahoma

Who Can Participate

Inclusion Criteria

Aged 4 to 80 years
Evidence of high-risk hematopoietic malignancy with relapsed/refractory disease: acute lymphocytic leukemia, Acute myeloid leukemia, Ambiguous lineage leukemia, myeloma
Karnofsky/Lansky score of ≥ 50
Agree to use contraceptive measures during study protocol participation (when age appropriate)
Patient or parent/guardian capable of providing informed consent.
Ability to undergo 18F FLT imaging without sedation
Bilirubin \< 2.5 mg/dL, AST/ALT \<5x upper limit of normal, Serum creatinine \< 1.0 or 2x the upper limit of normal (whichever is higher)
Pulse oximetry of \> 90% on room air
Ability to undergo 18F FLT imaging without sedation
Anticipated immunotherapy (Arm A to include patients who received immune therapy with co-enrollment on a separate protocol or other immunotherapy) and Arm B, those who received other non-immune therapies to treat their cancers (excludes HSCT but includes chemotherapy or non-HSCT radiotherapy).

Exclusion Criteria

Patients with uncontrolled infections
Pregnancy or lactating
History of prior fluorothymidine allergy or intolerance.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Washington Dc?

Yes, this clinical trial (NCT03633955) has an active research site in Washington Dc, DC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Acute Lymphocytic Leukemia Treatment Options in Washington Dc, DC

If you're searching for acute lymphocytic leukemia treatment options in Washington Dc, DC, this clinical trial (NCT03633955) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Washington Dc research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced acute lymphocytic leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all acute lymphocytic leukemia clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in Washington Dc, DC

See all leukemia clinical trials recruiting in Washington Dc — not just this study.

Browse Leukemia Trials in Washington Dc →

Browse More Trials by Condition

Leukemia TrialsHeart Attack TrialsPulmonary Hypertension TrialsInterstitial Cystitis TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Washington Dc?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Washington Dc, DC